Chinook Therapeutics Announces $106 Million Private Placement Financing to Advance Precision Medicines for Kidney Disease
VANCOUVER, British Columbia & SEATTLE–(BUSINESS WIRE)–Chinook Therapeutics, Inc., a privately held clinical-stage biotechnology company focused